These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25239128)

  • 1. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
    Fluur C; Bolse K; Strömberg A; Thylén I
    J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
    Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
    Thylén I; Moser DK; Strömberg A
    BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.
    MacIver J; Tibbles A; Billia F; Ross H
    SAGE Open Med; 2016; 4():2050312116642693. PubMed ID: 27110361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
    Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
    Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study.
    Lee KS; Oh O; Miller J; Hammash M; Thompson DR; Ski CF; Cameron J; Hwang SY; Moser DK
    Eur J Cardiovasc Nurs; 2022 Oct; 21(7):687-693. PubMed ID: 35018427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moral Distress at the End of a Life: When Family and Clinicians Do Not Agree on Implantable Cardioverter-Defibrillator Deactivation.
    Steiner JM; Patton KK; Prutkin JM; Kirkpatrick JN
    J Pain Symptom Manage; 2018 Feb; 55(2):530-534. PubMed ID: 29191724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.
    Gonzalez-Jaramillo V; Sobanski P; Calvache JA; Arenas-Ochoa LF; Franco OH; Hunziker L; Eychmüller S; Maessen M
    Palliat Med; 2020 Sep; 34(8):1019-1029. PubMed ID: 32588755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.
    Stoevelaar R; Stoppelenburg A; van Bruchem-Visser RL; van Driel AG; Theuns DA; Lokker ME; Bhagwandien RE; Heide AV; Rietjens JA
    Palliat Med; 2021 May; 35(5):904-915. PubMed ID: 33845683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator devices: when, how and who should discuss deactivation with patients: a systematic literature review.
    Freemantle M; Murtagh F
    BMJ Support Palliat Care; 2022 Dec; 12(4):359-367. PubMed ID: 33963003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
    Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normativity under change: Older persons with implantable cardioverter defibrillator.
    Svanholm JR; Nielsen JC; Mortensen PT; Christensen CF; Birkelund R
    Nurs Ethics; 2016 May; 23(3):328-38. PubMed ID: 25566813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator (ICD) functionality: patient and family information for advanced decision-making.
    Hill LM; McIlfatrick S; Taylor B; Dixon L; Fitzsimons D
    BMJ Support Palliat Care; 2022 Jul; 12(e2):e219-e225. PubMed ID: 31771959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.